4
Changes in Ownership
Opus Genetics, Inc. Filed Acc 0001140361-18-044426
Options or other derivatives
- Director acquired 112,878 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Price Ben Gil · Director
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2018-11-29 | Grant or award : show line 1 in the form Stock Option (right to buy) | +112,878 | $1.10 | 2028-11-29 | 112,878 | 112,878 | D |
Loading xslF345X03/form4.xml…